Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration has approved Aptivus, a nonpeptidic protease inhibitor from Boehringer-Ingelheim. The drug was shown to be effective against PI-resistant strains of HIV. Aptivus, now available nationwide, should be taken with a booster dose of Norvir. __________ Drugmaker Roche has advised health care professionals that it will stop sales and distribution of Fortovase, one of its protease inhibitors, by February 15 because of low demand. Roche's Invirase'which, like Fortovase, is a formulation of saquinavir'will continue to be available. __________ A pilot study in the July 1 edition of the Journal of Acquired Immune Deficiency Syndromes has shown that a nucleoside-sparing regimen containing just Kaletra and Sustiva is as effective as most three-drug regimens in reducing blood-based HIV viral loads and boosting CD4-cell counts. __________ HIV patients failing to achieve adequate blood-based concentrations when taking standard doses of the protease inhibitor Kaletra rarely achieve therapeutic levels by boosting their Kaletra dosage, according to a study in the July 1 edition of the journal AIDS. Drug side effects also were more likely with dosage increases. __________ A skin-patch test that screens for high levels of CD8 cells is effective in diagnosing risk factors for serious and possibly life-threatening hypersensitivity reactions to the nucleoside analog Ziagen. Researchers suggest combining the skin-patch test with immunological and genetic screenings to help diagnose and prevent Abacavir Hypersensitivity Syndrome. __________ Pfizer has announced it is abandoning development of experimental nonnucleoside analog capravirine because tests showed it was not more effective than existing antiretroviral drugs. __________ Tibotec is launching an expanded access program for the experimental protease inhibitor TMC114. Tests have shown that TMC114 is active against protease-resistant strains of HIV. Tibotec says that in 2006 it will seek accelerated approval for the drug. __________ Gilead Sciences has launched a Phase I/II study of its experimental integrase inhibitor GS 9137, which aims to prevent HIV from integrating viral genetic material into cellular DNA, a step necessary for the virus to replicate. The drug was previously evaluated in a Phase I trial in Japan. __________ A study in the July edition of The Annals of Pharmacotherapy has shown that once-daily administration of Ziagen is as effective in suppressing HIV replication as a twice-daily dosing, but the dose was linked with increased risk for hypersensitivity reactions and severe diarrhea. __________ Bristol-Myers Squibb has cut the price in poor nations of pediatric formulations of Zerit and Videx. Zerit's price was reduced by 44%; Videx's price was cut by 90%.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
Meet ​our Health Hero of the Year, Armonté Butler
October 21 2024 12:53 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM
Check out our 2024 year-end issue!
October 28 2024 2:08 PM
AIDS/LifeCycle is ending after more than 30 years
October 17 2024 12:40 PM
Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
October 15 2024 5:03 PM